MP
Therapeutic Areas
Integra LifeSciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CUSA® Clarity Ultrasonic Surgical Aspirator System | Cardiac Surgeries | Approved |
| Integra® Dermal Regeneration Template | Dermal Tissue Regeneration (Burns/Wounds) | Approved |
| DuraGen® Dural Graft Matrix | Dura Mater Repair (Neurosurgery) | Approved |
| NeuraGen® Nerve Guide | Peripheral Nerve Repair | Approved |
| SurgiMend® Collagen Matrix | Soft Tissue Reconstruction (Hernia, Plastic Surgery) | Approved |
| MicroMatrix® UBM Particulate | Acute and Chronic Wounds | Approved |
| Gentrix® Surgical Matrix | Soft Tissue Repair | Approved |
| DuraSorb® Monofilament Mesh | Reinforcement of Soft Tissue | Approved |
Leadership Team at Integra LifeSciences
AC
Andrea Caruso
Corporate Vice President, Strategy and Business Development
RT
Robert T. Davis, Jr.
Executive Vice President & President, Tissue Technologies
KD
Kerri DiPietro
Corporate Vice President & Chief Quality Officer
TE
Teshtar Elavia
Corporate Vice President and Chief Technology Officer
MH
Michael Hutchinson
Executive Vice President, Chief Legal Officer & Company Secretary
TK
Topaz Kirlew
Interim Chief Regulatory Officer
LD
Lea Daniels Knight
Executive Vice President & Chief Financial Officer
DK
Dimitri Kvares
Corporate Vice President & Chief Information Officer
RM
Rick Maveus
Senior Vice President, Transformation and Program Management Office
MM
Michael McBreen
Executive Vice President & President, Codman Specialty Surgical